Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Urine Analysis Pipeline Market Report Overview

Urine analysis refers to the analysis of urine to aid in the diagnosis of disease or to detect the presence of a specific substance. The Urine Analysis pipeline market research report provides comprehensive information about the Urine Analysis pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Urine Analyzers

·        Urine Analyzer Reagents

Key Territories ·        The US

·        Europe

·        South Korea

·        United Kingdom

·        Canada

Key Regulatory Paths ·        510(k)

·        CE-IVD

·        MDITAC

·        MDL

·        Ninsho

Leading Companies ·        A. Menarini Diagnostics Ltd

·        Analyticon Biotechnologies AG

·        Astrego Diagnostics AB

·        Bisu Inc

·        California Pacific Medical Center Research Institute

·        Clinical Design Technologies Ltd

·        Eone Diagnomics Genome Center Co Ltd

·        First Light Diagnostics Inc

·        Healthy io Ltd

·        Imperial College London

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Urine Analysis Pipeline Market by Segments

The key segments in the urine analysis pipeline market are urine analyzers and urine analyzer reagents. As of November 2023, urine analyzers has the highest number of pipeline products.

Urine Analysis Pipeline Market Analysis by Segments, 2023 (%)

Urine Analysis Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into the Urine Analysis Pipeline Market

Download A Free Report Sample

Urine Analysis Pipeline Market Segmentation by Territories

Some of the key territories in the urine analysis market are the US, Europe, South Korea, the UK, and Canada. As of November 2023, the US has the highest number of pipeline products.

Urine Analysis Pipeline Market Analysis by Territories, 2023 (%)

Urine Analysis Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into the Urine Analysis Pipeline Market

Download A Free Report Sample

Urine Analysis Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the urine analysis pipeline market are 510(k), CE-IVD, MDITAC, MDL, and Ninsho, among others. As of November 2023, 510(k) is the most followed pathway for pipeline products in the market.

Urine Analysis Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Urine Analysis Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into the Urine Analysis Pipeline Market

Download A Free Report Sample

Urine Analysis Pipeline Market – Competitive Landscape

Some of the key companies in the urine analysis pipeline market are A. Menarini Diagnostics Ltd, Analyticon Biotechnologies AG, Astrego Diagnostics AB, Bisu Inc, California Pacific Medical Center Research Institute, Clinical Design Technologies Ltd, Eone Diagnomics Genome Center Co Ltd, First Light Diagnostics Inc, Healthy io Ltd, and Imperial College London.

Analyticon Biotechnologies AG: It is a medical device company that develops, manufactures, and distributes diagnostic systems. The company provides products in the areas of urine diagnostics and hematology. The company’s products are used as diagnostic solutions in physician’s offices, hospitals, and clinical laboratories. It distributes products in Europe, the Middle East, Africa, and Americas through a network of distributors. Analyticon is headquartered in Lichtenfels, Germany.

Sysmex Astrego Diagnostics AB: It is a vitro diagnostic company that provides fully automated Antibiotic Susceptibility Testing (AST) that is quick, sensitive, and accurate for usage in central lab settings and close to patients. The Sysmex Astrego AST system can be utilized for quick susceptibility testing and bacterial infection diagnosis in UTI patients at the Point of Care. Sysmex is headquartered in Uppsala, Sweden.

Urine Analysis Pipeline Market Analysis by Companies, 2023

Urine Analysis Pipeline Market Analysis by Companies, 2023

Buy Full Report for More Company Insights into the Urine Analysis Pipeline Market

Download A Free Report Sample

Segments Covered in the Report

Urine Analysis Pipeline Market Segments Outlook

  • Urine Analyzers
  • Urine Analyzer Reagents

Urine Analysis Pipeline Market Territories Outlook

  • The US
  • Europe
  • South Korea
  • United Kingdom
  • Canada

Urine Analysis Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE-IVD
  • MDITAC
  • MDL
  • Ninsho

Scope

This report provides:

  • Extensive coverage of the Urine Analysis under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of Urine Analysis and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

This report provides:

  • Extensive coverage of the Urine Analysis under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of Urine Analysis and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

A.Menarini Diagnostics Ltd
Analyticon Biotechnologies AG
Astrego Diagnostics AB
Bisu Inc
California Pacific Medical Center Research Institute
Clinical Design Technologies Ltd
Eone Diagnomics Genome Center Co Ltd
First Light Diagnostics Inc
Healthy io Ltd
Imperial College London
Indian Institute of Technology Delhi
IRIS International Inc
LifeAssays AB
NTBIO Diagnostics Inc
QSTAG Co Ltd
Sebia
Siemens Healthcare Diagnostics Inc
Singapore General Hospital
Stanford University
Teco Diagnostics
University of Kentucky
Withings SA

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Urine Analysis Overview

  • 3 Products under Development

    • 3.1 Urine Analysis – Pipeline Products by Stage of Development
    • 3.2 Urine Analysis – Pipeline Products by Segment
    • 3.3 Urine Analysis – Pipeline Products by Territory
    • 3.4 Urine Analysis – Pipeline Products by Regulatory Path
    • 3.5 Urine Analysis – Pipeline Products by Estimated Approval Date

  • 4 Urine Analysis – Pipeline Products under Development by Companies

    • 4.1 Urine Analysis Companies – Pipeline Products by Stage of Development
    • 4.2 Urine Analysis – Pipeline Products by Stage of Development

  • 5 Urine Analysis Companies and Product Overview

    • 5.1 A.Menarini Diagnostics Ltd Company Overview

      • 5.1.1 A.Menarini Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Analyticon Biotechnologies AG Company Overview

      • 5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Astrego Diagnostics AB Company Overview

      • 5.3.1 Astrego Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Bisu Inc Company Overview

      • 5.4.1 Bisu Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 California Pacific Medical Center Research Institute Company Overview

      • 5.5.1 California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Clinical Design Technologies Ltd Company Overview

      • 5.6.1 Clinical Design Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Eone Diagnomics Genome Center Co Ltd Company Overview

      • 5.7.1 Eone Diagnomics Genome Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 First Light Diagnostics Inc Company Overview

      • 5.8.1 First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Healthy io Ltd Company Overview

      • 5.9.1 Healthy io Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Imperial College London Company Overview

      • 5.10.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Indian Institute of Technology Delhi Company Overview

      • 5.11.1 Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 IRIS International Inc Company Overview

      • 5.12.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 LifeAssays AB Company Overview

      • 5.13.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 NTBIO Diagnostics Inc Company Overview

      • 5.14.1 NTBIO Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 QSTAG Co Ltd Company Overview

      • 5.15.1 QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Sebia Company Overview

      • 5.16.1 Sebia Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Siemens Healthcare Diagnostics Inc Company Overview

      • 5.17.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Singapore General Hospital Company Overview

      • 5.18.1 Singapore General Hospital Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Stanford University Company Overview

      • 5.19.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Teco Diagnostics Company Overview

      • 5.20.1 Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 University of Kentucky Company Overview

      • 5.21.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 Withings SA Company Overview

      • 5.22.1 Withings SA Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Urine Analysis- Recent Developments

    • 6.1 Sep 11, 2023: Dirui Industrial Appoints Lin Maoliang as Non-Independent Directors
    • 6.2 Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
    • 6.3 Jul 10, 2023: Keystone Lab Announces Addition of Xylazine Testing to Its In-House Menu
    • 6.4 Jun 20, 2023: Veravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis
    • 6.5 May 12, 2023: Horiba announces summary of consolidated financial statements for the three months ended March 31, 2023
    • 6.6 Apr 03, 2023: Shanghai Kehua’s Board Elects Li Ming As Company President
    • 6.7 Mar 28, 2023: EKF Diagnostics Holdings Announces its final results for the year ended 31 December 2022
    • 6.8 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
    • 6.9 Feb 14, 2023: Horiba Announces Summary of Consolidated Financial Statements for the Year Ended December 31, 2022
    • 6.10 Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
    • 6.11 Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors
    • 6.12 Feb 01, 2023: Techno Medica Announces Non-consolidated Financial Results for the Nine Months Ended December 31, 2022
    • 6.13 Jan 06, 2023: Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Urine Analysis – Pipeline Products by Stage of Development 9_x000D_

Urine Analysis – Pipeline Products by Segment 10_x000D_

Urine Analysis – Pipeline Products by Territory 11_x000D_

Urine Analysis – Pipeline Products by Regulatory Path 12_x000D_

Urine Analysis – Pipeline Products by Estimated Approval Date 13_x000D_

Urine Analysis Companies – Pipeline Products by Stage of Development 14_x000D_

Urine Analysis – Pipeline Products by Stage of Development 15_x000D_

A.Menarini Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 16_x000D_

Sedimax Lite – Product Status 16_x000D_

Sedimax Lite – Product Description 16_x000D_

Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 17_x000D_

Urilyzer 100 Pro – Product Status 17_x000D_

Urilyzer 100 Pro – Product Description 17_x000D_

Urilyzer 500 Pro – Product Status 18_x000D_

Urilyzer 500 Pro – Product Description 18_x000D_

Astrego Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 19_x000D_

PA-100 Analyser With PA AST Panel U-0501 – Product Status 19_x000D_

PA-100 Analyser With PA AST Panel U-0501 – Product Description 20_x000D_

Bisu Inc Pipeline Products & Ongoing Clinical Trials Overview 21_x000D_

Bisu Body Coach – Product Status 21_x000D_

Bisu Body Coach – Product Description 21_x000D_

Fertility Test Stick – Product Status 22_x000D_

Fertility Test Stick – Product Description 22_x000D_

Oral Health Test Stick – Product Status 22_x000D_

Oral Health Test Stick – Product Description 22_x000D_

California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview 23_x000D_

Urinary Proteome Monitoring Assay – Product Status 23_x000D_

Urinary Proteome Monitoring Assay – Product Description 23_x000D_

Clinical Design Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 24_x000D_

Urine Testing System – Product Status 24_x000D_

Urine Testing System – Product Description 24_x000D_

Eone Diagnomics Genome Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25_x000D_

Uriwell – Product Status 25_x000D_

Uriwell – Product Description 26_x000D_

First Light Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 27_x000D_

MultiPath Immunoreagent – UTI – Product Status 27_x000D_

MultiPath Immunoreagent – UTI – Product Description 27_x000D_

Healthy io Ltd Pipeline Products & Ongoing Clinical Trials Overview 28_x000D_

Home Based Dipstick Analyzer – Skincare – Product Status 28_x000D_

Home Based Dipstick Analyzer – Skincare – Product Description 28_x000D_

Minuteful 10 – Product Status 29_x000D_

Minuteful 10 – Product Description 29_x000D_

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 30_x000D_

Diagnostic Test – Autism – Product Status 30_x000D_

Diagnostic Test – Autism – Product Description 30_x000D_

Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 31_x000D_

Opto-Electronic Sensor – Micro-Albumin – Product Status 31_x000D_

Opto-Electronic Sensor – Micro-Albumin – Product Description 31_x000D_

IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview 32_x000D_

3GEMS Next Generation Urinalysis Platform – Product Status 32_x000D_

3GEMS Next Generation Urinalysis Platform – Product Description 32_x000D_

LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview 33_x000D_

LifeAssays U-Albumin – Product Status 33_x000D_

LifeAssays U-Albumin – Product Description 33_x000D_

NTBIO Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 34_x000D_

Urine Analyzer – Product Status 34_x000D_

Urine Analyzer – Product Description 34_x000D_

QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 35_x000D_

Qscheck-UIS Ketogenic Diet Kit – Product Status 35_x000D_

Qscheck-UIS Ketogenic Diet Kit – Product Description 35_x000D_

Qscheck-UIS4 Kit – Product Status 36_x000D_

Qscheck-UIS4 Kit – Product Description 36_x000D_

Sebia Pipeline Products & Ongoing Clinical Trials Overview 37_x000D_

Capillarys 3 Tera Assay – Urine – Product Status 37_x000D_

Capillarys 3 Tera Assay – Urine – Product Description 37_x000D_

Capillarys 3 Tera Assay – Urine IT – Product Status 38_x000D_

Capillarys 3 Tera Assay – Urine IT – Product Description 38_x000D_

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 39_x000D_

Clinitek Atlas Next – Product Status 39_x000D_

Clinitek Atlas Next – Product Description 39_x000D_

Singapore General Hospital Pipeline Products & Ongoing Clinical Trials Overview 40_x000D_

Urine Biochemistry Device – Product Status 40_x000D_

Urine Biochemistry Device – Product Description 40_x000D_

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 41_x000D_

Biostrip Test – Urine Analysis – Product Status 41_x000D_

Biostrip Test – Urine Analysis – Product Description 41_x000D_

Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 42_x000D_

Next Generation Urine Analyzer – Product Status 42_x000D_

Next Generation Urine Analyzer – Product Description 42_x000D_

University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview 43_x000D_

Diagnostic Gene-Expression Test – Interstitial Cystitis – Product Status 43_x000D_

Diagnostic Gene-Expression Test – Interstitial Cystitis – Product Description 43_x000D_

Withings SA Pipeline Products & Ongoing Clinical Trials Overview 44_x000D_

U-Scan – Product Status 44_x000D_

U-Scan – Product Description 44_x000D_

Glossary 55_x000D_

Figures

Urine Analysis – Pipeline Products by Stage of Development 9_x000D_

Urine Analysis – Pipeline Products by Segment 10_x000D_

Urine Analysis – Pipeline Products by Territory 11_x000D_

Urine Analysis – Pipeline Products by Regulatory Path 12_x000D_

Urine Analysis – Pipeline Products by Estimated Approval Date 13_x000D_

Frequently asked questions

Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.